Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Intramuscular Sabin IPV and Intradermal Fractional Sabin IPV
NCT05460377Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Centers for Disease Control and Prevention. Started Jul 2022; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT05460377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460377.